New flowchart could reduce ICU time and pacemakers after TAVR

NCT ID NCT05417464

Completed Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a simple flowchart to help doctors monitor and manage heart conduction problems after transcatheter aortic valve replacement (TAVR). The goal was to see if this approach could safely reduce the need for intensive care and permanent pacemakers. Researchers followed 250 patients and tracked serious conduction issues and pacemaker use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Use of a flowchart for screening, monitoring, and management of conductive disorders
What this could lead to: If successful, this strategy could reduce the need for intensive care and pacemakers after TAVR, leading to shorter hospital stays and lower costs.
What could go wrong: This is a completed observational study, not a treatment trial. The flowchart is a management tool, so it cannot cure or directly treat heart disease. Results may not apply to all hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VALVULAR HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis heart valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VALVULAR HEART DISEASE

Contacts and locations

Locations

University Hospital

Montpellier, France, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.